Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes

被引：0
|
作者：
Hundal, Ripu S.
Kowalyk, Stephan
Cases, Jane
Al-Karadsheh, Amer
Wakim, Amanda P.
Doyle, Melissa
Sink, John H., II
Spence, Adrienne
Brewer, Jamie L.
Nikkel, Carla C.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-989-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Insulin and Glucagon Secretion during 75 g OGTT before and after Liraglutide Treatment May Predict Therapeutic Response in Type 2 Diabetes when Switching from Basal-Bolus Insulin Therapy to Combination of Liraglutide and Basal Insulin
    Horie, Ichiro
    Abiru, Norio
    Haraguchi, Ai
    Sako, Ayaka
    Niri, Tetsuro
    Norimura, Ayako
    Natsuda, Shoko
    Mori, Yoshitaka
    Ando, Takao
    Kawakami, Atsushi
    DIABETES, 2017, 66 : A295 - A295
  • [32] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
    Kerlan, Veronique
    Gouet, Didier
    Marre, Michel
    Renard, Eric
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
  • [33] The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
    Klimontov, V. V.
    Myakina, N. E.
    DIABETES MELLITUS, 2015, 18 (04): : 66 - 71
  • [34] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
  • [35] Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano, D.
    Sieradzki, J.
    Stefanski, A.
    Gentilella, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1425 - 1434
  • [36] The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
    Ozturkmen, Yuksel Asli
    Avci, Suna
    Calim, Aslihan
    Cetin, Elif Guven
    Demir, Nazan
    Mazi, Emrah Erkan
    Borlu, Fatih
    Altuntas, Yuksel
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (04): : 416 - 423
  • [37] COST-EFFECTIVENESS OF SWITCHING TO INSULIN ASPART FROM HUMAN SOLUBLE INSULIN IN CHINESE PATIENTS WITH TYPE-2 DIABETES ON A BASAL-BOLUS REGIMEN
    Ji, Q. H.
    Ye, Q.
    Zhang, Y. Z.
    VALUE IN HEALTH, 2013, 16 (03) : A164 - A165
  • [38] Insulin Degludec: Reduction of Hypoglycemia during Basal-Bolus Therapy in Patients with Diabetes Mellitus Type 1 or 2
    Luedemann, J.
    Merker, L.
    Milek, K.
    Kaiser, M.
    Wilhelm, B.
    DIABETOLOGIE UND STOFFWECHSEL, 2013, 8 (01) : 35 - 42
  • [39] Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal-Bolus Therapy
    Langer, Jakob
    Wolden, Michael L.
    Shimoda, Seiya
    Sato, Miki
    Araki, Eiichi
    DIABETES THERAPY, 2019, 10 (04) : 1347 - 1356
  • [40] CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO® DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN
    Lajara, Rosemarie
    Davidson, Jaime A.
    Nikkel, Carla C.
    Morris, Tracy L.
    ENDOCRINE PRACTICE, 2016, 22 (06) : 726 - 735
12345